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Abstract 
Prediction of three-dimensional structure of cathepsins, and molecular dynamics simulations of cathepsin S were studied by 
interaction with the drug molecule with virtual screening 681,158 compounds from ZINC database. The result of study 
showed top 1 ranked was obtained with drug molecule ZINC 23215439 reaction with cathepsin S. This demonstrates that 
the active site of cathepsin S Cys25, His164 and binding site Gln19 and Gly 20 are essential for interactions of cathepsin S-
ZINC 23215439 inhibitor complex. Coulomb-SR and Lennard-Jones-SR interactions energy of amino acids and drug 
molecule ZINC code 23215439 which consisted in active site of cathepsin S have been evaluated.  
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1. Introduction  
Cathepsins are proteases that break apart other proteins, found in many types of cells including those in all 
animals. There are approximately a dozen members of this family, which are distinguished by their structure, 
catalytic mechanism, and proteins that are by them cleaved.  Most of the members become activated at the low 
pH found in lysosomes >1@. Thus, the activity of this family lies almost entirely within those organelles. In this 
research purpose to study on three-dimensional structural investigation of cathepsins in cysteine proteinase C1 
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papain family was carried out by Homology modeling method >2-3@. Cathepsin S is a lysosomal enzyme that 
belongs to the papain family of cysteine proteases as a potential target for anti-cancer cancer therapy [4]. The 
protein structure of cathepsin S (EC 3.4.22.27) is highly similar to several members of the family, with for 
example 57% sequence identity to cathepsin L and K and approximately 30% identity to cathepsin B [5] 
Virtual screening of cathepsin S reactions with drug-like molecules from ZINC database were investigated and 
study on phenomenon a motion of protein structure in particular of active site with both free and complex of 
cathepsin S by using molecular docking studies. Virtual screening is a computational technique used in drug 
discovery research. It involves the rapid in silico assessment of large libraries of chemical structures in order to 
identify those structures that most likely to bind to a drug target, typically a protein receptor or enzyme >6@. 
Virtual screening has become an integral part of the drug discovery process >7-9@. Virtual screening is an 
emerging technology that is gaining an increased role in the drug discovery process. The technique involves 
analyzing large collections of compounds, leading to smaller subsets for biological testing >10@. It is now 
perceived as a complementary approach to experimental screening and, when coupled with structural biology, 
promised to enhance the probability of success in the lead identification stage of the drug discovery process. 
Structure-based virtual screening of cathepsin S for use as potential anticancer drug requires computational 
fitting of compounds into an active site of a receptor by use of sophisticated algorithms, followed by scoring 
and ranking of these compounds to identify potential leads >11-12@.  
2. Methods 
2.1. Predictions of three-dimensional structure of cathepsins 
Homology modeling method 
No X-ray crystal structures of cathepsins 1, 2, 3, 6, Q, P, m, R, W and O. have been deposited in the protein 
Data Bank based on the amino acid sequence from GeneBank and UniProt Database [13].     X-ray 
crystallography structure of cathepsins in C1 cystein protienase family were obtained from the Brookhaven 
Protein Data Bank [14]. These models of three-dimensional structures were used as the template structure for 
prediction three-dimensional structure of cathepsins. The models of three-dimensional structure of cathepsins 
was generated using the homology module of Insight II [15] based on X-ray crystallographic structure of 
template which showed the highest identity percentage by using Geno3D. Geno3D is an automatic web server 
for protein molecular modeling [16]. The searching of the template structure was determined by starting with a 
query protein sequence, the server performs  in three successive steps were identified homologous proteins with 
known three-dimensional structures by using PSI-BLAST, provide the user all potential templates through a 
very convenient user interface for target selection and perform the alignment of both query and subject 
sequence. The sequences of cathepsins and template were aligned by homology module to identify the blocks 
that are likely to contain structurally conserved region. All atomic coordinates of the residues in those blocks 
were transferred from template to build the modeled structure of cathepsins. However, for the mismatch 
residues, only the atomic coordinate of CD were transferred from template while the residual atomic coordinate 
were generated by using library.  
Energy minimization 
All hydrogen atoms were added to the homology-modeled structure of cathepsin by a builder module and 
then were energy-minimized by discovery module of Insight II. The minimization was performed with a 5Ǻ-
water layer in dimensions of 60x60x60 Ǻ in a water box. First, the steepest descent algorithm followed by the 
more efficient conjugate gradient was reached. After minimization, the layer water was removed. Validation of 
the model was carried out using Ramachandran plot calculations computed with the Procheck program [17].  
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Superimposing cathepsins structures 
Superimposing cathepsins structures were generated by using Discovery Studio (DS) V2.5 [18]. The first 
step in comparing different cathepsin structures is to superimpose the structures based on either their c-alpha or 
backbone atoms. Since different cathepsins have different numbers and types of residues, the residues to be 
used must be known to map the coordinates from different cathepsin structures. DS provides a method for 
superimposing cathepsin structures specific matching residues between two cathepsins and superimposes them 
based on their sequence alignment, and then the matching residues for superimposition are automatically 
identified based on the aligned residues in the sequence alignment. The root-mean-square deviation (RMSD) 
was determined for the superimposition and the number of residues used to superimpose the cathepsins is used 
to measure the differences between values predicted by a model and the values actually observed. 
2.2. Virtual screening study 
The studies of three-dimensional structure of cathepsins papain C1 family involves the assignment of 
cathepains have already been deposited  and compared with no X-ray crystal structures of cathepsins have been 
deposited in public Protein Data Bank to account  for protein structures. To understand molecular recognition 
in cathepsin-substrate system for structure-based drug design, however, it is necessary to consider the 
interdependence of binding interactions of all cathepsins papain C1 family. This dynamics aspect of molecular 
recognition of cathepsin S is one of least well understood aspect of molecular recognition.  Structure-based 
virtual screening involves docking of candidate ligands into a protein target followed by applying a scoring function 
to estimate the ligand will bind to the protein with high affinity. The drug subset of the ZINC database was 
selected to study [19]. Cathepsin S, the cysteine proteinase has been used as target for virtual screening in this 
study. The coordinate the X-ray crystal structure of this enzyme (PDB 2R9M) was retrieved from the Protein 
Data Bank. Active compounds with molecular weights between on 200-600 daltons were selected as drug-like 
compounds from ZINC database. DOCK program (version 6.1) were selected for molecular docking studies 
>20@. The small molecules from drug-like compounds of ZINC database were initial screen based on method of 
Lipinski’s rule of five including ADME-Tox >21@. The small molecules which have heavy metal and toxic 
atom, aromatic ring more than 2 rings, the ring size more than 6 carbons and the charge more than +2 and less 
than -2 were removed from the database. The screening active compounds (681,158 molecules) were 
performed virtual screening with flexible docking and with grid energy scoring function. The final coordinates 
of each molecule were then stored in multi-mol2 files. The top-ranked 10 drug-like compounds were collected 
based on free energy binding and grid score for the last step. The energy scores and contact scores of DOCK 
were used in this work.  
2.3. Molecular dynamics simulations studies 
All simulations in this research were performed using the GROMACS (version 3.3.3) package [22]. The 
OPLS-AA/L all-atom force field was used for protein and SPC set as water model. The amino acids name Lys, 
Arg and Gln were set to +1 while Glu and Asp were set to -1. The minimum angle for hydrogen bonding was 
set to 135° and maximum distance of donor-acceptor was set to 30 Å. The box model was set to cubic by 
specified the distance between the solute and the box as 8 Å and also set the protein to the center of the system. 
The atom ion name Na+ and Cl- were selected for this research by specified salt concentration as 0.02 M and set 
the option (-neutral) until the system became to neutralize. In order to performed molecular dynamic 
simulations, first step, the system was run energy minimization. In the second step, the output obtained from 
energy minimization was continued with pre-MD simulation until the solvent system became to equilibrium. In 
the last step, the output obtained from pre-MD simulation was continued with full molecular dynamic 
simulations from 0 until 20 ns.  
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3. Results 
3.1. Prediction of three-dimensional structure of cathepsins by homology modeling method 
The results of prediction three-dimensional structure of cathepsins in C1 family that have not been 
determined structures by X-ray crystallography were shown in Fig 1. The structure of cathepsins were 
generated by homology module using Insight II program based on the X-ray structure which showed the 
highest identity percentage, as shown in Table 1. The three-dimensional structures of cathepsin in C1 Family 
have been solved by X-ray crystallography available at Protein Data Bank such as cathepsins V, X, S, L, K, H, 
F and B. According to superimpositions of cathepsin in C1 family, we found that the structure of cathepsins 
have been identified into 3 groups; group 1 showed % identity less than 20 Å with model of three-dimensional 
structure of cathepsins 1, 2, 3, 6, F, H, L, K, O, P, Q, R, S, V and W. Group 2 has only cathepsin B as a 
member and group 3 has only cathepsin X as a member because they both have % identity more than 20 Å, 
when compared with the another as shown in Fig 2. 
 
 
 
Fig. 1. Overall predictions models of three-dimensional structures of cathepsin 1, 2, 3, 6, M, O, P, Q, R and W by Homology Modeling 
method. The catalytic dyads (cysteine and histidine were shown under structure. 
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Table 1. Templates used for three-dimensional structure prediction of each sequences of cathepsins. 
 
Enzyme Enzyme Template calculated by Geno 3D server 
PDB Code Enzyme template % identity 
Cathepsin 1 1fh0 Cathepsin V 56 
Cathepsin 2 1fh0 Cathepsin V 62 
Cathepsin 3 1fh0 Cathepsin V 56 
Cathepsin 6 1fh0 Cathepsin V 59 
Cathepsin Q 3hha Cathepsin L 61 
Cathepsin P 1fh0 Cathepsin V 58 
Cathepsin M 1fh0 Cathepsin V 64 
Cathepsin R 3hha Cathepsin L 62 
Cathepsin W 1me3 Cruzain 54 
Cathepsin O 1fh0 Cathepsin V 62 
 
 
 
 
 
Fig. 2. Superimposition of all cathepsins three-dimensional structures in papain C1 family based on carbon backbone. 
 
3.2. Virtual Screening 
The results of virtual screening studies between cathepsin S and 681,158 active compounds as drug-like 
compounds from ZINC database, which are drug now subset and initial screen based on method of Lipinski’s 
rule of five including ADME-Tox was studied. Drug-like compounds are interacts with cathepsin S, that have 
lowest energy value top 10 ranked compounds as shown in Table 2. The binding site of cathepsin S for drug-
like compounds interactions were shown in Fig 3. The result showed indicating that drug-like compounds 
bound in the active site within 2 parts. These parts are S and S′ subsites. 
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Table 2. Top 10 rank drug-like compound molecules interactions with cathepsin S. 
 
Rank        Zinc code                                        IUPAC Name  Grid Score Free energy 
binding 
1 ZINC23215439 (5Z)-2-[(2,5-dimethylphenyl)amino]-5-[[3-methoxy-4-(2-
morpholino-2-oxo-ethoxy)phenyl]methylene]thiazol-4-one 
-38.393898 -39.092602 
2 ZINC25514259 N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-methyl-2-[(2-oxo-
1,3-dihydrobenzimidazol-5-yl)sulfonylamino]benzamide 
-37.235909 -32.429466 
3 ZINC09185764 5-(2-furyl)-4-(damanti-phenyl-methylene)-1-[2-(1H-indol-3-
yl)ethyl]pyrrolidine-2,3-dione 
-36.491997 -32.623199 
4 ZINC22681343 3-(1,3-benzodioxol-5-yl)-N-[(2R)-2-(4-methyl-1-piperidyl)-2-(2-
thienyl)ethyl]propanamide 
-36.359833 -34.095329 
5 ZINC20057950 (5S)-4-(4-chlorobenzoyl)-5-(2-chlorophenyl)-3-hydroxy-1-(2-
morpholinoethyl)-5H-pyrrol-2-one 
-36.338936 -33.565563 
6 ZINC22918093 1-[[4-(1,3-benzothiazol-2-ylmethyl)piperazin-1-yl]methyl]-2-
(phenoxymethyl)benzimidazole 
-36.169193 -35.388580 
7 ZINC13123165 (4E,5R)-4-[damanti-(p-tolyl)methylene]-1-[2-(1H-indol-3-
yl)ethyl]-5-(3-pyridyl)pyrrolidine-2,3-dione 
-36.140175 -34.131016 
8 ZINC23640419 N-[4-[4-[(5-chloro-2-thienyl)methyl]piperazin-1-yl]-4-oxo-
butyl]damantine-1-carboxamide 
-35.677483 -35.067104 
9 ZINC20855900 N-[3-[(3R,5R)-3,5-dimethyl-1-piperidyl]propyl]-1-(1H-imidazol-4-
ylsulfonyl)piperidine-4-carboxamide 
-35.623291 -31.000479 
10 ZINC09124349 N-[1-methyl-2-(2-morpholinoethyl)benzoimidazol-5-yl]-2-(4-
methyl-1-oxo-phthalazin-2-yl)-acetamide 
-35.349407 -33.785519 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. The result from virtual screening of cathepsin S with drug-like compounds. There are top 100 ranked superimposed from free 
energy binding. The structure of cathepsin S was shown in electrostatic surface by representing of drug-like compounds with stick. The 
binding mode was divided into 2 parts, S and S´ subsites. These parts were shown with yellow dashed circle. 
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Fig. 4. (A) Electrostatic surface representation of cathepsin S in complex with top-ranked 1, ZINC 23215439. The ZINC 23215439 was 
shown fit well in the part of S and S′ subsites of the active site of cathepsin S. (B) The molecular docking model of interactions in a 
cathepsin S-ZINC23215439 inhibitors adsorptive complex. Catalytic dyads of cathepsin S amino acid residues Cys25 and His164 are 
formed hydrogen bonds towards the O2 and O4 of ZINC23215439, respectively. The P1 subsite of ZINC23215439 inhibitor is formed 
hydrogen bond towards the Trp186 and Gln19. 
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Fig. 5. (A) Electrostatic surface representation of cathepsin S in complex with top-ranked 25, ZINC 06660322. The ZINC06660322 was 
shown fit well in the part of S and S′ subsites of the active site of cathepsin S. (B) The molecular docking model of interactions in a 
cathepsinS-ZINC06660322 inhibitors adsorptive complex. The P1 and P´2 subsites of ZINC06660322 inhibitor are formed hydrogen bonds 
towards the Phe146, Trp186 and Gln19. 
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Fig. 6. Coulomb-SR interactions energy of amino acids and drug molecule ZINC 23215439 (blue), ZINC 25514259(red) and ZINC 09185764 
(green) which consisted in active site of cathepsin S were evaluated from molecular dynamics simulations during 20 ns. 
 
 
Fig. 7. Lennard-Jones-SR interactions energy of amino acids and drug-like molecule ZINC 23215439 (blue), ZINC 25514259 (red) and ZINC 
09185764 (green) which consisted in active site of cathepsin S. were evaluated from molecular dynamics  simulations during 20 ns. 
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Fig. 8. Comparison of Root Mean Square Deviation of amino acids and drug molecule ZINC 23215439 (blue),  
ZINC 25514259 (red) and ZINC 09185764 (green) interactions with active site of cathepsin S.  
 
The ribbon structure of cathepsin S complex with the best drug-like compound, ZINC 23215439 was shown 
in Fig 4A. The molecular docking model of interactions in cathepsin S-ZINC 23215439 inhibitor adsorptive 
complex was shown in Fig 4B. The binding interactions between of cathepsin S and ZINC 23215439 complex 
showed 7 hydrogen bonds within 3.5 Å. The amino acid residues of cathepsin S which form hydrogen bonds 
and interact with drug-like compound ZINC 23215439 are Cys 25…O2, Trp168…S1, Gln19…S1, Gln19…N1 
and His164…O4. Comparison with the ribbon structure of cathepsin S complex with top-rank 25 drug-like 
compounds ZINC06660322 was shown in Fig 5 A and B. The result was shown that missing on hydrogen 
bonding interactions in between of active site amino acid residues of cathephin S and ZINC06660322. 
Coulomb-SR interactions energy amino acids in active site of cathepsin S-ZINC 23215439, 25514259 and 
09185764 complex were shown in Fig 6. The result of Lennard-Jones-SR interactions energy of amino acids in 
active site of cathepsin S –complex with ZINC code 23215439, 25514259 and 09185764 was shown in Fig 7. 
Comparison of Root mean square deviation (RMSD) of amino acids in active site of cathepsin S and drug-like 
molecules ZINC 23215439, 25514259 and 09185764 were evaluated from molecular dynamics simulations 
studies on during 20 nanosecond as shown in Fig 8.  
4. Conclusions 
The characteristics of active site and structure-based virtual screening of cathepsin S reactions with small 
molecules of drug-like compounds from the ZINC database Version 8 were investigated. The S and S′ subsites 
of cathepsin S were clearly classified based on molecular docking and virtual screening. Several of amino acid 
residues in the S subsite represented the hydrophobic pocket. More 60 % of the active small molecules based 
on virtual screening preferred S subsite rather than S′ subsite. The 10 top ranked drug-like compounds were 
classified to possess the lowest free energy of binding and grid score for cathepsin S. The result of top 1 ranked 
drug-like compounds reaction with cathepsin S was also studied by molecular docking. The results of these 
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studies are compared with those of top 2 and 3 ranked drug-like compounds from ZINC database in which that 
hydrogen bonds are essential for binding interactions between amino acid residues Cys25, His164, Gln19, 
Trp186 and Phe 146 of cathepsin S and inhibitors. Root Mean Square Deviation, Coulomb-SR and Lennard-
Jones-SR interactions energy of amino acids and drug molecule ZINC 23215439 which consisted in active site 
of cathepsin S have been evaluated from molecular dynamics simulations during 20 nanoseconds. The values 
indicated that drug molecule ZINC 23215439 in which that hydrophobic interaction are essential for binding 
interactions between cathepsin S and inhibitors. The potentials of these cathepsin S inhibitors for anticancer 
therapy are now under intensive investigation in many academic institutions and pharmaceutical companies, 
and that attention is also being paid to the possibility of these inhibitors in controlling the inhibition and 
progression of immune disorders such as multiple sclerosis, rheumatoid arthritis, allergic asthma and pain.  
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